IVERIC bio Inc. sell Marianka
Start price
20.06.22
/
50%
€8.81
Target price
20.06.23
€4.00
Performance (%)
10.05%
End price
26.06.22
€9.69
Summary
This prediction ended on 26.06.22 with a price of €9.69. The prediction closed with a disappointing performance of 10.05%. Marianka has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| IVERIC bio Inc. | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% |
According to Marianka what are the pros and cons of IVERIC bio Inc. for the foreseeable future?
Pros
Standard Investments for future growth
Good culture
Some uniques
Differentiated customer and product portfolio
Sustainability is important
Known brand
Cons
Probably not worthwhile Investment
Revenue decline > 20% expected
Lower EBIT Margin than peer group
EBIT decline > 20% expected
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
High risks in the balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Little innovation
Growths much slower than the competition
high free float
Higher risks for its business
Below average Marketposition
Very high cyclical dependencies
Outdated or very high risk business model